Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients

    October 2018 in “ Medical Science Monitor ”
    Senem Senturk, Safak Hatirnaz, Mine Kanat-Pektas
    Studysummary This study concluded that PCOS patients, regardless of weight, have significantly lower serum amylin levels than healthy BMI-matched controls, while serum preptin levels did not vary significantly between groups.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on medscimonit.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Epidemiology, Diagnosis, and Management of Polycystic Ovary Syndrome Clinical epidemiology · 2013
    2. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome Fertility and Sterility · 2004